Pfizer Securities Fraud Suit Must Stay In NJ: Judge

By Hilary Russ ( April 5, 2011, 7:43 PM EDT) -- A federal judge on Tuesday rejected an attempt by Pfizer Inc. to move one of three securities fraud lawsuits over an Alzheimer's treatment drug to New York, leaving the class action to proceed in New Jersey....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login